Biohit
3.03
EUR
-0.66 %
Corporate customer
BIOBV
NASDAQ Helsinki
Medical Equipment & Services
Health Care
4,825 following
Income statement
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 9.0 | 9.9 | 10.1 | 7.1 | 9.4 | 11.0 | 13.1 | 14.3 | 17.6 | 19.6 | 22.5 |
growth-% | 10.6 % | 1.2 % | -29.1 % | 31.4 % | 17.0 % | 19.2 % | 9.8 % | 22.7 % | 11.5 % | 15.0 % | |
EBITDA | 7.9 | -0.2 | 0.6 | -1.2 | 0.5 | 1.6 | 2.1 | 2.8 | 3.1 | 3.6 | 4.6 |
EBIT (adj.) | 6.4 | -2.0 | -1.4 | -3.2 | -1.5 | 1.1 | 1.8 | 2.4 | 2.8 | 3.1 | 4.0 |
EBIT | 6.4 | -2.0 | -1.4 | -3.2 | -1.5 | 1.1 | 1.8 | 2.4 | 2.8 | 3.1 | 4.0 |
Profit before taxes | 6.4 | -2.0 | -1.2 | -3.3 | -1.3 | 0.9 | 2.2 | 2.7 | 3.0 | 3.3 | 4.2 |
Net income | 6.1 | -2.1 | -1.4 | -3.3 | -1.5 | 0.6 | 1.8 | 2.3 | 2.4 | 2.7 | 3.4 |
EPS (adj.) | -0.14 | -0.09 | -0.22 | -0.10 | 0.04 | 0.12 | 0.15 | 0.16 | 0.18 | 0.22 | |
growth-% | 189.9 % | 33.3 % | 3.6 % | 10.6 % | 26.0 % | ||||||
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.05 | 0.07 |
Dividend ratio | 25.0 % | 30.0 % | 30.0 % |
Profitability and return on capital
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|---|---|---|
EBITDA-% | 88.5 % | -1.6 % | 5.9 % | -16.5 % | 5.4 % | 14.7 % | 16.1 % | 19.8 % | 17.8 % | 18.6 % | 20.5 % |
EBIT-% (adj.) | 70.8 % | -19.8 % | -14.0 % | -44.6 % | -15.8 % | 10.3 % | 13.4 % | 17.0 % | 15.7 % | 16.0 % | 17.8 % |
EBIT-% | 70.8 % | -19.8 % | -14.0 % | -44.6 % | -15.8 % | 10.3 % | 13.4 % | 17.0 % | 15.7 % | 16.0 % | 17.8 % |
ROE | -12.8 % | -9.2 % | -28.3 % | -18.5 % | 8.0 % | 20.6 % | 21.8 % | 18.4 % | 17.4 % | 19.0 % | |
ROI | -11.5 % | -8.9 % | -25.9 % | -17.7 % | 14.3 % | 19.1 % | 23.1 % | 22.6 % | 21.7 % | 23.8 % |
Valuation
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|---|---|---|
Share price (EUR) | 3.77 | 2.96 | 3.36 | 2.48 | 1.84 | 1.57 | 1.92 | 3.03 | 3.03 | 3.03 | 3.03 |
Shares | 15.0 | 15.0 | 15.0 | 15.0 | 15.0 | 15.1 | 15.1 | 15.1 | 15.1 | 15.1 | |
Market cap | 44.3 | 50.6 | 37.3 | 27.7 | 23.6 | 29.0 | 45.8 | 45.8 | 45.8 | 45.8 | |
Enterprise value | 35.3 | 41.9 | 31.6 | 22.3 | 18.3 | 24.5 | 38.5 | 36.0 | 34.4 | 32.4 | |
EV/S | - | 3.6 | 4.2 | 4.4 | 2.4 | 1.7 | 1.9 | 2.7 | 2.0 | 1.8 | 1.4 |
EV/EBITDA | - | - | 70.5 | - | 44.0 | 11.4 | 11.7 | 13.6 | 11.5 | 9.5 | 7.0 |
EV/EBIT (adj.) | - | - | - | - | - | 16.3 | 14.0 | 15.8 | 13.0 | 11.0 | 8.1 |
EV/EBIT | - | - | - | - | - | 16.3 | 14.0 | 15.8 | 13.0 | 11.0 | 8.1 |
P/E (adj.) | - | - | - | - | - | 39.3 | 16.6 | 19.6 | 19.0 | 17.1 | 13.6 |
P/E | - | - | - | - | - | 39.3 | 16.6 | 19.6 | 19.0 | 17.1 | 13.6 |
P/B | - | 2.8 | 3.4 | 4.2 | 3.8 | 3.1 | 3.1 | 3.8 | 3.2 | 2.8 | 2.4 |
P/S | - | 4.5 | 5.0 | 5.2 | 3.0 | 2.2 | 2.2 | 3.2 | 2.6 | 2.3 | 2.0 |
Dividend yield | 1.3 % | 1.8 % | 2.2 % | ||||||||
Equity ratio | 92.0 % | 89.7 % | 84.4 % | 81.6 % | 76.7 % | 68.7 % | 73.1 % | 85.3 % | 85.0 % | 85.2 % | 85.3 % |
Gearing ratio | -47.9 % | -55.7 % | -59.2 % | -64.7 % | -72.4 % | -69.8 % | -47.6 % | -61.4 % | -68.1 % | -69.4 % | -70.8 % |
Quarter data
Q3/23 | Q4/23 | 2023 | Q1/24 | Q2/24 | Q3/24e | Q4/24e | 2024e | Q1/25e | |
---|---|---|---|---|---|---|---|---|---|
Revenue | 6.6 | 13.1 | 7.4 | 6.9 | 14.3 | ||||
EBITDA | 0.4 | 2.1 | 1.5 | 1.4 | 2.8 | ||||
EBIT | 0.3 | 1.8 | 1.3 | 1.2 | 2.4 | ||||
Profit before taxes | 0.5 | 2.2 | 1.5 | 1.3 | 2.7 | ||||
Net income | 0.5 | 1.8 | 1.3 | 1.1 | 2.3 |